Literature DB >> 12591740

Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.

Pang-Dian Fan1, Feng Cong, Stephen P Goff.   

Abstract

Oligomerization of the nonreceptor tyrosine kinase c-Abl can activate its transforming potential. Domains mediating oligomerization within the BCR-ABL and TEL-ABL oncoproteins are required for transforming activity, and fusion of inducible dimerization domains to c-Abl can generate chimeric proteins with dimerization-dependent transforming activity. We have found that c-Abl oligomerizes at high levels of expression in COS cells. This interaction is dependent on kinase activity and an intact NH(2)-terminal region of c-Abl. A binding partner of c-Abl, Abl-interactor-1 (Abi-1), similarly oligomerizes in COS cells. An oligomeric form of Abi-1 interacts with Abl both in vitro and in mammalian cells. These results suggest the possibility that oligomerization of Abl kinases, perhaps involving regulation by their interaction partners, may play a role in modulation of kinase activity in both normal and oncogenic processes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591740

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl.

Authors:  Amina El Jamali; Anthony J Valente; James D Lechleiter; Maria J Gamez; Doran W Pearson; William M Nauseef; Robert A Clark
Journal:  Free Radic Biol Med       Date:  2007-12-08       Impact factor: 7.376

Review 2.  BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors.

Authors:  Wanlong Ma; Hagop Kantarjian; Chen-Hsiung Yeh; Zhong J Zhang; Jorge Cortes; Maher Albitar
Journal:  Acta Haematol       Date:  2009-03-31       Impact factor: 2.195

Review 3.  Steering cell migration: lamellipodium dynamics and the regulation of directional persistence.

Authors:  Matthias Krause; Alexis Gautreau
Journal:  Nat Rev Mol Cell Biol       Date:  2014-09       Impact factor: 94.444

4.  Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.

Authors:  Balázs Merő; László Radnai; Gergő Gógl; Orsolya Tőke; Ibolya Leveles; Kitti Koprivanacz; Bálint Szeder; Metta Dülk; Gyöngyi Kudlik; Virág Vas; Anna Cserkaszky; Szabolcs Sipeki; László Nyitray; Beáta G Vértessy; László Buday
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

Review 5.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

6.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

7.  Abl interactor 1 (Abi-1) wave-binding and SNARE domains regulate its nucleocytoplasmic shuttling, lamellipodium localization, and wave-1 levels.

Authors:  Asier Echarri; Margaret J Lai; Matthew R Robinson; Ann Marie Pendergast
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

8.  Crystal structure of an SH2-kinase construct of c-Abl and effect of the SH2 domain on kinase activity.

Authors:  Sonja Lorenz; Patricia Deng; Oliver Hantschel; Giulio Superti-Furga; John Kuriyan
Journal:  Biochem J       Date:  2015-06-01       Impact factor: 3.857

9.  Functional mechanisms and roles of adaptor proteins in abl-regulated cytoskeletal actin dynamics.

Authors:  Mizuho Sato; Masahiro Maruoka; Tatsuo Takeya
Journal:  J Signal Transduct       Date:  2012-05-17

Review 10.  Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.

Authors:  Guilherme A P de Oliveira; Luciana P Rangel; Danielly C Costa; Jerson L Silva
Journal:  Front Oncol       Date:  2015-04-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.